PCN155 - Cost effectiveness of Nivolumab for patients with advanced, previously treated renal cell carcinoma in Scotland

Mahon, S., Bullement, A. orcid.org/0000-0001-7091-0972, Willis, A. et al. (5 more authors) (2017) PCN155 - Cost effectiveness of Nivolumab for patients with advanced, previously treated renal cell carcinoma in Scotland. In: Value in Health. ISPOR 20th Annual European Congress, 04-08 Nov 2017, Glasgow, Scotland. Elsevier , A440.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. For re-use permissions, please contact the authors.
Dates:
  • Published (online): 20 October 2017
  • Published: 4 November 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 04 Feb 2021 09:27
Last Modified: 06 Feb 2021 05:48
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jval.2017.08.238
Related URLs:

Download

Filename: Mahon 2017.pdf

Description: Conference poster

Share / Export

Statistics